A case of idiopathic adulthood ductopenia with drug-induced liver damage

[2]Ludwig J, Wiesner RH, LaRusso NF.Idiopathic adulthood duc-topenia.A cause of chronic cholestatic liver disease and biliary cir-rhosis[J].J Hepatol, 1988, 7 (2) :193-199.

[3]Zhang WS, Wang BE, Jia JD.Idiopathic adult intrahepatic bile ductdeficiency[J].Chin Hepatol, 2004, 9 (4) :264-266. (in Chinese) 张文胜, 王宝恩, 贾继东.特发性成人肝内胆管缺失症[J].肝脏, 2004, 9 (4) :264-266.

[4]Reily CA.Familial intrahepatic cholestatic syndromes[J].SeminLiver Dis, 1987, 7 (2) :119-133.

[5]Bruguera M, Llach J, Rodès J.Nonsyndromic paucity of intrahepat-ic bile ducts in infancy and idiopathic ductopenia in adulthood:thesame syndrome?[J].Hepatology, 1992, 15 (5) :830-834.

[6]Burak KW, Pearson DC, Swain MG, et al.Familial idiopathic a-dulthood ductopenia:a report of five cases in three generations[J].J Hepatol, 2000, 32 (1) :159-163.

[7]Chia SC, Bergasa NV, Kleiner DE, et al.Pruritis as a presentingsymptom of chronic hepatitis C[J].Dig Dis Sci, 1998, 43 (10) :2177-2183.

[8]Dural AT, Genta RM, Goodman ZD, et al.Idiopathic adulthoodductopenia associated with hepatitis C virus[J].Dig Dis Sci, 2002, 47 (7) :1625-1626.

[9]Khanlou H, Sass D, Rothstein K, et al.Idiopathic adulthood duc-topenia:case report and review of the literature[J].Arch InternMed, 2000, 160 (7) :1033-1036.

[10]Moreno A, Carreo V, Cano A, et al.Idiopathic biliary ductopeniain adults without symptoms of liver disease[J].N Engl J Med, 1997, 336 (12) :835-838.

[11]Hartmann H, Grne HJ.Idiopathic ductopenia of adulthood:favor-able effect of ursodeoxycholic acid therapy[J].Z Gastroenterol, 1993, 31 (Suppl 2) :131-133.

[12]Zhang WS, Wang BE, Jia JD, et al.Idiopathic adulthood ductopenia:report of one case[J].Chin J Hepatol, 2005, 13 (9) :714-712. (inChinese) 张文胜, 王宝恩, 贾继东, 等.特发性成人肝内胆管缺失症1例报道[J].中华肝脏病杂志, 2005, 13 (9) :714-717.

[13]Park BC, Park SM, Choi EY, et al.A case of idiopathic adulthoodductopenia[J].Korean J Intern Med, 2009, 24 (3) :270-273.

Relative Articles

[1]	Ziyun GUO, Lina DU, Xiaoxuan XIE, Yan YANG. Level of vitamin D in children with cholestatic liver disease and its clinical features[J]. Journal of Clinical Hepatology, 2025, 41(1): 99-103. doi: 10.12449/JCH250115
[2]	Jiping ZHANG. Pathological diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1093-1099. doi: 10.12449/JCH240605
[3]	Qingqing ZHANG, Ying QU, Xiaobo CAI, Lungen LU. Research advances in animal models of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1754-1760. doi: 10.3969/j.issn.1001-5256.2023.07.035
[4]	Jing LI, Kuiyang ZHENG, Beibei ZHANG. Mechanism of action of bile acid metabolism in regulating cholestatic liver disease and the research and development of drugs[J]. Journal of Clinical Hepatology, 2021, 37(10): 2482-2487. doi: 10.3969/j.issn.1001-5256.2021.10.048
[5]	Hua HaiYang, Li JianHui, Su Bin, Xuan XiaoYu. Liver subcapsular biliary cyst successfully treated by endoscopic retrograde cholangiopancreatography: A case report[J]. Journal of Clinical Hepatology, 2020, 36(6): 1354-1355. doi: 10.3969/j.issn.1001-5256.2020.06.034
[6]	Guo MengMeng, Xie Wen. New therapeutic targets and drugs for cholestatic liver disease[J]. Journal of Clinical Hepatology, 2019, 35(2): 262-265. doi: 10.3969/j.issn.1001-5256.2019.02.005
[7]	Mao Qing. Pathogenesis and management strategies of liver failure-associated cholestasis[J]. Journal of Clinical Hepatology, 2019, 35(2): 258-261. doi: 10.3969/j.issn.1001-5256.2019.02.004
[8]	Chen RuiLing, Ma Xiong. Pathogenesis of cholestasis-induced liver fibrosis and thoughts for blockade[J]. Journal of Clinical Hepatology, 2019, 35(2): 247-251. doi: 10.3969/j.issn.1001-5256.2019.02.002
[9]	Kan YanTing, Yang YongFeng. Role of cholestatic liver disease-related genes in intrahepatic cholestasis of pregnancy[J]. Journal of Clinical Hepatology, 2019, 35(7): 1439-1443. doi: 10.3969/j.issn.1001-5256.2019.07.006
[10]	Xu JiaMin, Tang YingMei. Current status of research on bile duct lesions and related liver diseases[J]. Journal of Clinical Hepatology, 2019, 35(4): 934-936. doi: 10.3969/j.issn.1001-5256.2019.04.051
[11]	Jiang Chao, Huang HeYu, Lu: GuoYue. Perspectives of liver transplantation for infantile cholestatic liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1928-1930. doi: 10.3969/j.issn.1001-5256.2017.10.015
[12]	Yang ShiZhong, Xiang CanHong. Surgical treatment of congenital bile duct dilatation with involvement of the intrahepatic bile duct:advances,difficulties,and controversy[J]. Journal of Clinical Hepatology, 2017, 33(2): 263-267. doi: 10.3969/j.issn.1001-5256.2017.02.011
[13]	Li XiaoFeng, Gong JingYu, Wang JianShe. Association between enterohepatic circulation of bile acid and cholestatic liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1922-1927. doi: 10.3969/j.issn.1001-5256.2017.10.014
[14]	Li Hua, Li YiMing, Lu Le. Mechanism of α-naphthyl isothiocyanate inducing cholestatic hepatitis: a preliminary study[J]. Journal of Clinical Hepatology, 2016, 32(5): 933-937. doi: 10.3969/j.issn.1001-5256.2016.05.026
[15]	Sun FengXia, Sui JingLi, Li Pan, Wang Man, Wu Fang, Li XiaoLing. Biochemical parameters in diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2016, 32(8): 1488-1490. doi: 10.3969/j.issn.1001-5256.2016.08.011
[16]	Li Lei, Li Bing, Ding HuiGuo. Effect of ursodeoxycholic acid on bile secretion after endoscopic nasobiliary drainage in patients with cholestatic liver disease of various causes[J]. Journal of Clinical Hepatology, 2016, 32(3): 522-525. doi: 10.3969/j.issn.1001-5256.2016.03.026
[17]	Ge HongYan, Wang YingShu. Clinical efficacy of glucocorticoid therapy in treatment of drug-induced cholestatic liver disease[J]. Journal of Clinical Hepatology, 2015, 31(10): 1618-1620. doi: 10.3969/j.issn.1001-5256.2015.10.014
[18]	Zhang QiDi, Lu LunGen. Mechanisms and treatment of cholestasis- induced liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 337-341. doi: 10.3969/j.issn.1001-5256.2015.03.005
[19]	Fan HeBin, Li Zhi, Li Jian, Chen AnShen, Xu LiTong, Zhou Hao, Tian ZhanFei, Ma XiaoJu, Sun Jie, Yan FuMing. The clinical features and prognosis of sepsis-associated cholestasis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(3): 208-210.
[20]	Qu Ying, Xu MingYi, Lu LunGen. Current progress in understanding of cholestasis and autoimmune liver diseases——Meeting review about 1st symposium on cholestasis and autoimmune liver disease[J]. Journal of Clinical Hepatology, 2011, 27(2): 222-225.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3084) PDF downloads(655)

A case of idiopathic adulthood ductopenia with drug-induced liver damage

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

A case of idiopathic adulthood ductopenia with drug-induced liver damage

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content